跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 314 条关于
“PARPi”
全部
314
临床试验
207
药物
53
机构
2
资讯
52
去年
ctDNA Analysis Reveals Mechanisms of PARP Inhibitor Resistance in Prostate Cancer
5年前
Comparative Analysis of PARP Inhibitors in BRCA-Mutated Ovarian Cancer Shows Similar Efficacy and Toxicity
去年
Blood Test Detects PARPi Resistance in Ovarian Cancer Patients with BRCA1 Mutations
去年
Blood Test Detects PARPi Resistance in Ovarian Cancer Patients with BRCA1 Mutations
2年前
Mirvetuximab Soravtansine Shows Promise in Platinum-Sensitive Ovarian Cancer
3年前
Repare Therapeutics' ATR Inhibitor Camonsertib Shows Promise in DNA Repair-Deficient Cancers
2年前
ESMO 2024: AbbVie and Nuvalent Present Promising Data on Novel Cancer Therapies
2个月前
KMT2 Mutations Predict Immunotherapy Benefit in Esophageal Adenocarcinoma, Not Squamous Cell Carcinoma
5个月前
NIH-Sponsored Trial Shows Stent Placement Significantly Reduces Post-Thrombotic Syndrome Severity
6年前
PARP Inhibitors Show Similar Efficacy in BRCA-Mutated Ovarian Cancer, Cost-Effectiveness Varies
第 1 页,共 6 页
上一页
下一页